SCHEMBL1206715

SCHEMBL1206715

CCCc1ccc(/C=C/C(=O)O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.67
ALDH1A1 P00352 2/20 0.67
HPGD P15428 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
MITF O75030 1/20 0.67
KLF5 Q13887 1/20 0.67
HCAR2 Q8TDS4 2/20 0.55
ESR1 P03372 2/20 0.55
ESR2 Q92731 2/20 0.55
CA12 O43570 1/20 0.55
AKR1B10 O60218 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA3 P07451 1/20 0.55
PKM P14618 1/20 0.55
TYR P14679 1/20 0.55
AKR1B1 P15121 1/20 0.55
CA4 P22748 1/20 0.55
CA6 P23280 1/20 0.55
DPP4 P27487 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1206716 1.00 KDM4E (0.67) KDM4EALDH1A1HPGDSMN1; SMN2MITF
Hydrochloric Acid SCHEMBL11768179 0.98 KDM4E (0.65) KDM4EALDH1A1HPGDSMN1; SMN2MITF
SCHEMBL7966311 0.95 KDM4E (0.70) KDM4EALDH1A1HPGDSMN1; SMN2MITF
SCHEMBL7966308 0.95 KDM4E (0.70) KDM4EALDH1A1HPGDSMN1; SMN2MITF
SCHEMBL1206905 0.89 ALDH1A1 (0.63) KDM4EALDH1A1HPGDSMN1; SMN2MITF
SCHEMBL28614845 0.89 ALDH1A1 (0.63) KDM4EALDH1A1HPGDSMN1; SMN2MITF
SCHEMBL1206901 0.89 ALDH1A1 (0.63) KDM4EALDH1A1HPGDSMN1; SMN2MITF
SCHEMBL846032 0.88 ALDH1A1 (0.69) KDM4EALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL846033 0.88 ALDH1A1 (0.69) KDM4EALDH1A1HPGDSMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL11763070 0.88 ALDH1A1 (0.61) KDM4EALDH1A1HPGDSMN1; SMN2MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5961875-A Antifreeze/coolant composition containing cinnamic acid CCI CO., LTD. (JP) 1999-10-05 US claimed
EP-4619378-A2 IONIZABLE LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACIDS Seawolf Therapeutics, Inc. (US) 2025-09-24 EP disclosed
CN-120202184-A Ionizable lipids and lipid nanoparticle compositions for delivery of nucleic acids 海狼治疗公司 2025-06-24 CN disclosed
WO-2024107906-A2 IONIZABLE LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACIDS SEAWOLF THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed
WO-2024107906-A2 IONIZABLE LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACIDS SEAWOLF THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed
US-11253596-B2 Phenylalkylcarboxylic acid delivery agents NOVO NORDISK NORTH AMERICA OPERATIONS A/S (DK) 2022-02-22 US disclosed
US-20200405863-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS NOVO NORDISK A/S (DK) 2020-12-31 US disclosed
US-10456472-B2 Phenylalkylcarboxylic acid delivery agents EMISPHERE TECHNOLOGIES, INC. (US) 2019-10-29 US disclosed
EP-2114145-B1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECH INC (US) 2017-11-01 EP disclosed
US-20160375135-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECHNOLOGIES, INC. (US) 2016-12-29 US disclosed
US-5708018-A 2-aminoindans as selective dopamine D3 ligands PHARMACIA & UPJOHN COMPANY (US) 1998-01-13 US disclosed
US-5539074-A LIQUID CRYSTAL POLYMERS ON SILICA FOR LIGHT SENSITIVE ELEMENTS HOFFMANN-LA ROCHE INC. (US) 1996-07-23 US disclosed
EP-0712387-A1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS PHARMACIA & UPJOHN COMPANY (US) 1996-05-22 EP disclosed
WO-1995004713-A1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS THE UPJOHN COMPANY (US) 1995-02-16 WO disclosed
US-RE32944-E Aromatic carboxylic amide derivatives Kissei Yakuhin Kogyo Kabushiki (JP) 1989-06-06 US disclosed
US-4070484-A Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same KISSEI PHARMACEUTICAL CO., LTD. (JA) 1978-01-24 US disclosed
US-4061587-A Liquid crystalline cinnamic acid esters HOFFMANN-LA ROCHE INC. (US) 1977-12-06 US disclosed
US-4026896-A ANTIALLERGENS KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (KISSEI PHARMACEUTICAL CO. LTD.) (JA) 1977-05-31 US disclosed
US-3962219-A DISTYRYL-BENZOBISOXAZOLES BAYER AKTIENGESELLSCHAFT (DT) 1976-06-08 US disclosed
US-3940422-A ANTIALLERGEN KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (JA) 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200405863-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA KDM4E 2723/4885ALDH1A1 599/4885HPGD 1242/4885
US-10456472-B2 Phenylalkylcarboxylic acid delivery agents PGF, LIPA, PDGFA KDM4E 2723/4885ALDH1A1 599/4885HPGD 1242/4885
US-11253596-B2 Phenylalkylcarboxylic acid delivery agents PGF, LIPA, PDGFA KDM4E 2723/4885ALDH1A1 599/4885HPGD 1242/4885
US-20160375135-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA KDM4E 2723/4885ALDH1A1 599/4885HPGD 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.